Miftahussurur M et al. |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. |
2016 |
BMC Microbiol. |
pmid:27809767
|
Phaw NA and Tsai HH |
Eosinophilic gastroenteritis: a challenge to diagnose and treat. |
2016 |
BMJ Case Rep |
pmid:27613263
|
Plate A |
[Not Available]. |
2016 |
Praxis (Bern 1994) |
pmid:27606919
|
Huh CW et al. |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. |
2016 |
PLoS ONE |
pmid:27588679
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Büchsel M et al. |
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia. |
2016 |
Diagn. Microbiol. Infect. Dis. |
pmid:27342785
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
Zollner-Schwetz I et al. |
Primary resistance of Helicobacter pylori is still low in Southern Austria. |
2016 |
Int. J. Med. Microbiol. |
pmid:27134190
|
Georgopoulos SD et al. |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. |
2016 |
Eur. J. Intern. Med. |
pmid:27134145
|
Blake Z |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction. |
2016 |
BMJ |
pmid:26955978
|
Seyama S et al. |
Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26953210
|
Ji Z et al. |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China. |
2016 |
Medicine (Baltimore) |
pmid:26937912
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Iyer G and Alexander GC |
Cardiovascular risks associated with clarithromycin. |
2016 |
BMJ |
pmid:26769796
|
Wong AY et al. |
Cardiovascular outcomes associated with use of clarithromycin: population based study. |
2016 |
BMJ |
pmid:26768836
|
Djennane-Hadibi F et al. |
High-Level Primary Clarithromycin Resistance of Helicobacter pylori in Algiers, Algeria: A Prospective Multicenter Molecular Study. |
2016 |
Microb. Drug Resist. |
pmid:26554340
|
Siddiqui TR et al. |
Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: The need for consideration of amoxicillin and clarithromycin. |
2016 |
J Pak Med Assoc |
pmid:27339574
|
Apostolopoulos P et al. |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. |
2016 |
Scand. J. Gastroenterol. |
pmid:26435055
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|